Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.47 USD | +1.50% | +3.61% | +32.45% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.45% | 2.35B | |
+12.51% | 3,144B | |
+12.68% | 88.51B | |
-14.00% | 54.56B | |
+26.21% | 48.26B | |
-22.56% | 47.95B | |
+25.42% | 44.14B | |
+69.48% | 39.42B | |
-8.00% | 25.26B | |
+26.00% | 23.15B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite DI : Needham & Co Starts Cellebrite at Buy with $12 Price Target